This reduction in the proinflammatory milieu may explain the beneficial effects of GLP-1 agonists on liver histology [19], especially in the knowledge that persistent inflammation drives fibrosis in NASH. Here, GCG is linked to metabolic dysfunction-associated steatohepatitis.